Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 5—May 2005
Dispatch

Antibody Testing and Lyme Disease Risk

Elizabeth G. Stone*Comments to Author , Eleanor H. Lacombe*, and Peter W. Rand*
Author affiliations: *Maine Medical Center Research Institute, South Portland, Maine, USA

Main Article

Figure 1

Canine Lyme disease seroprevalence rates based on the IDEXX 3Dx test for minor civil divisions with ≥10 tests, Maine, 2003.

Figure 1. Canine Lyme disease seroprevalence rates based on the IDEXX 3Dx test for minor civil divisions with ≥10 tests, Maine, 2003.

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external